MedPath

A study to assess the effectiveness and value for money of a programme to prevent primary school age children becoming overweight and obese

Not Applicable
Completed
Conditions
Childhood obesity
Obesity
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN97000586
Lead Sponsor
niversity of Birmingham (UK)
Brief Summary

2013 pilot study results in: http://www.ncbi.nlm.nih.gov/pubmed/22302618 2014 process evaluation design in: http://www.ncbi.nlm.nih.gov/pubmed/25212062 2014 teacher experiences results in: http://hej.sagepub.com/content/early/2014/11/06/0017896914556907.abstract 2015 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25968599 2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/26671226 2015 parent and child perceptions in: http://www.ncbi.nlm.nih.gov/pubmed/26654046 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29436364 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29437667 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31291330 (added 27/02/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1397
Inclusion Criteria

All children (boys and girls) in year 1 (age 5-6) in schools participating in the trial

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> The difference in percentage of children categorised as normal weight, overweight and obese in control compared to intervention schools.<br> 1. The categorisation will be based primarily on height and weight measures and defined by BMI using cut-offs at the 85th and 95th percentiles on the UK 1990 reference charts for BMI centiles for boys and girls.<br> 2. Additional measures of obesity will also be used:<br> 2.1. Waist circumference<br> 2.2. Skinfold thickness at 4 sites (biceps, suprailiac, subscapular and thigh)<br> 2.3. Body fat calculated from a measure of bioimpedance (obtained from a Tanita body composition analyser)<br><br> All participants will undergo these measures at baseline, 1 year and 2 years. Wave one participants will undergo these measures a further time at 3 years.<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. 24 hour dietary assessment using a Child and Diet Evaluation Tool (CADET) tick list<br> 2. Physical activity levels measured over 5 days using an Actiheart monitor (combined heart rate monitor and accelerometer)<br> 3. Health-related quality of life measured by the Pediatric Quality of Life Inventory (PedsQL)<br> 4. Body image measure using an adapted version of the Collins Figure Rating Scale<br> 5. A further quality of life measure for use in the cost-effectiveness study will be developed at the start of the trial<br><br> All participants will undergo these measures at baseline, 1 year and 2 years. Wave one participants will undergo these measures a further time at 3 years.<br>
© Copyright 2025. All Rights Reserved by MedPath